London & Capital Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
London & Capital Asset Management's LLY Position: Q2 2026 in Review
London & Capital Asset Management increased its Eli Lilly (LLY) stake by 406% in Q2 2026, buying an estimated $1.63M and bringing the position to 1,987 shares worth $2.38M. The position accounts for 0.02% of the portfolio, ranked #84.
London & Capital Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- London & Capital Asset Management held 1,987 shares of Eli Lilly worth $2.38M as of Q2 2026.
- London & Capital Asset Management bought 1,594 Eli Lilly shares in Q2 2026, an estimated $1.63M.
- Eli Lilly made up 0.02% of London & Capital Asset Management's portfolio in Q2 2026, its #84 holding.
- London & Capital Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on London & Capital Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.